Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-29

Clinical Trial Update: A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high protein supplementation in HIV-positive patients with stable weight loss has completed. The National Institute of Allergy and In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High Protein Supplementation (protein supplement)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, HIV Wasting Syndrome | Phase 2 | Status: COMPLETED